Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 7/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8380588 | 1.00 | TSHR (0.50) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL27755160 | 1.00 | TSHR (0.50) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL8380482 | 1.00 | TSHR (0.50) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL6447684 | 1.00 | TSHR (0.50) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL8385766 | 1.00 | TSHR (0.50) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL5870114 | 1.00 | — | — | |
| SCHEMBL2567996 | 1.00 | — | — | |
| SCHEMBL8385629 | 1.00 | TSHR (0.50) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL16793280 | 1.00 | TSHR (0.50) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL9379976 | 0.97 | TSHR (0.47) | TSHRTHRBDNM1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108430583-A | The method for treating disease and illness using interleukin-10 | 阿尔莫生物科技股份有限公司 | 2018-08-21 | — | — | CN | disclosed |
| CN-108025040-A | The method that disease and illness are treated using interleukin-10 | 阿尔莫生物科技股份有限公司 | 2018-05-11 | — | — | CN | disclosed |
| CN-106999558-A | Base undecylate composition of (17 β) 3 oxygen androstane-14 alkene 17 and its production and use | 来普卡公司 | 2017-08-01 | — | — | CN | disclosed |
| CN-105939722-A | Tau peptides, anti-tau antibodies, and methods of use thereof | 伊皮埃里安股份有限公司 | 2016-09-14 | — | — | CN | disclosed |
| CN-101405240-B | Reagent for organic synthesis and method of organic synthesis reaction with the reagent | JITSUBO CO LTD | 2012-07-25 | — | — | CN | disclosed |
| CN-101405240-A | Reagent for organic synthesis and method of organic synthesis reaction with the reagent | JITSUBO CO LTD (JP) | 2009-04-08 | — | — | CN | disclosed |
| CN-1639188-A | Hepta-, octa-and nonapeptides with anti-angiogenic activity | ABBOTT LAB (US) | 2005-07-13 | — | — | CN | disclosed |
| CN-85105429-A | The preparation desugar is the method for the carboxylates derivatives of Aaron Copland peaceful (deglucoteicoplanin) too | — | 1987-01-14 | — | — | CN | disclosed |